Eligibility Criteria

• Are practicing medicine in northwestern Ontario

• Have experience diagnosing people with dementia

• Have practiced for a minimum of 1 year

• Speak English

OR

• Have been diagnosed with dementia between 1-5 years

• Lived in northwestern Ontario at the time of diagnosis

• Are currently living in northwestern Ontario

• Speak English

Eligibility Criteria

You are eligible to participate if you are:

1) Involved in dementia research or services

AND / OR

2) from an underserved group* in dementia research.

3)Aged 19 +

3)Able to complete the web-based survey in one of the following languages: English, French, Chinese (simplified), Punjabi, Inuktitut.

*Underserved groups in dementia research include: Racial/ethnic minorities (i.e., South Asian, Chinese, Black, Filipino, Arab, Latin American, Southeast Asian, West Asian, Korean, Japanese, or other racial/ethnic minority) Indigenous populations (i.e., First Nations, Inuit, Métis, or other Indigenous group), Sexual/gender minorities (i.e., the LGBTQ2S+ community), Individuals living in rural and/or remote communities, Individuals living with a disability, Individuals with low social and economic conditions.

Eligibility Criteria

You are eligible to participate if you:
- Speak English
- A person with memory problems experiencing eating challenges or swallowing problems in the community
- OR if you are or were a caregiver to a person with memory problems with eating challenges or swallowing problems.

Eligibility Criteria

Age 50 - 85
Mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease
Must have a study partner

Eligibility Criteria

60+
Diagnosis of Alzheimer's disease
Must have a study partner

Eligibility Criteria

You are eligible to participate if you meet the following criteria:

• Age ≥ 55; females must be post-menopausal

• DSM-5 criteria for Major Neurocognitive Disorder due to AD; multiple etiologies (AD and vascular)

• sMMSE ≤ 24

• Clinically significant agitation based on IPA definition

• Stable cognition-enhancing medication for at least 3 months prior to study enrolment

• Availability of a caregiver to accompany participant to study visits and to participate in the study

• Ability to speak English

Eligibility Criteria

Are a member of the TRIAD cohort at McGill University, falling within one of the following categories: young control, cognitively unimpaired, mild cognitive impairment, or Alzheimer's Disease.

Are willing and able to undergo advanced neuroimaging techniques including MRI and PET without contraindications.

Have not had any significant neurological conditions (other than AD for the AD group) that might interfere with the results of the study.

Have no metal implants, devices, or other conditions that may contraindicate or distort MRI imaging.

Are not currently participating in other clinical trials or studies that involve interventions which might interfere with the results of this study.

Are able and willing to provide informed consent for participation in the study or have a legally authorized representative who can do so.

Do not have a history of substance abuse or other conditions that might confound the imaging and cognitive data.

Have not undergone any significant head trauma or surgery in the past 6 months.

Are not pregnant or planning to become pregnant during the duration of the study.

Are willing to comply with all study-related procedures, imaging sessions, and follow-up evaluations.

Ability to speak English and French

Eligibility Criteria

You are eligible to participate if you...

Live in Canada

Are a Canadian citizen or permanent resident

Have a diagnosis of dementia, are a family member or a bereaved family member (within the last year) of a person living with dementia, or are a professional who works directly with people living with dementia or in palliative care

Are able to speak English

*We are primarily looking for people living with dementia and family members living in the community, especially from different cultural backgrounds.

Eligibility Criteria

Age 50 - 80
Mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease